Assessment of the Efficacy and Safety of EESS in Patients With Incomplete Spinal Cord Injuries

Recruiting N/A Interventional Study
Spinal Cord Injuries
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
14 (estimated)
Sponsor
Hopital Foch · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Neurological disability caused by traumatic lesions of the spinal cord is a significant challenge for medicine and society. These lesions, leading to sublesional central nervous system dysfunction, include sensorimotor, vesico-sphincter and genito-sexual disorders. To date, there is no treatment that enables spinal cord function to be restored. Preclinical studies have been able to demonstrate th…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Aged between 18 and 65 years inclusive * Male or female * Incomplete ASIA B or C spinal cord lesion with level of lesion located above T10 (sensation preserved below level of lesion) * Absence of significant motor deficit of the upper limbs or recovered motor deficit (muscular…
Contacts

Béchir Jarraya, MD

01 46 25 29 66

b.jarraya@hopital-foch.com

CONTACT

Marjolaine Ngollo, PhD

01 46 25 37 49

drci-promotion@hopital-foch.com

CONTACT